Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heart- and neural crest derivatives-expressed protein 1 (HAND1) is a basic helix-loop-helix (bHLH) transcription factor that plays a critical role in the development of the heart, extraembryonic tissues including the placenta, and neural crest derivatives. HAND1 is asymmetrically expressed during embryogenesis and is indispensable for cardiac morphogenesis, influencing processes such as ventricular chamber specification, septation, and conduction system development. Mutations or altered expression of HAND1 in animal models and humans cause a spectrum of congenital heart defects, including hypoplastic left heart syndrome, and are implicated in craniofacial abnormalities. HAND1 is also required for trophoblast differentiation in the placenta and participates in yolk sac vasculogenesis. Its dosage and expression must be precisely regulated during development, and no drugs are currently known to directly modulate HAND1 activity as it is a transcription factor, not a surface or catalytic target[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heart- and neural crest derivatives-expressed protein 1 (HAND1).